-
Quest Diagnostics Reports Weaker-Than-Expected Q1 Earnings
Wednesday, April 20, 2011 - 7:19am | 57Quest Diagnostics Inc (NYSE: DGX) reported its Q1 adjusted EPS at $1.00, missing the consensus of $1.01. DGX reported its Q1 revenue at $1.82 billion, versus the consensus of $1.81 billion. DGX shares gained 0.93% to close at $58.80 yesterday. Read more from Benzinga's Company news.
-
Quest Diagnostics Reports Q1 EPS of $1.00 vs. $1.01; Revenues $1.8B vs. $1.8B
Wednesday, April 20, 2011 - 7:02am | 21Quest Diagnostics (NYSE: DGX) Reports Q1 EPS of $1.00 vs. $1.01; Revenues $1.8B vs. $1.8B
-
Top 4 Small-Cap Stocks In The Medical Laboratories & Research Industry With The Highest EPS Estimates (ICLR, PRXL, BRLI, MTOX)
Wednesday, April 20, 2011 - 12:14am | 149Below are the top small-cap medical laboratories & research stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next year. The earnings estimate for ICON plc (NASDAQ: ICLR) for the next year ending December, 2012 is $1.54 per share. ICLR's trailing-twelve-month ROE is 14.02...
-
Options Brief: Quest Diagnostics Incorporated (DGX)
Tuesday, April 19, 2011 - 10:55am | 103Shares of Quest Diagnostics Incorporated (NYSE: DGX) are higher on the session by 0.55%, trading at $58.58. Overall call volume is now running at 3.37x the daily average, with 68% of all calls traded being purchases on the offer. 1,047 contracts have traded on the session so far. Quest...
-
LabCorp Commences Cash Tender Offer for All Outstanding Shares of Orchid Cellmark at $2.80 per Share
Tuesday, April 19, 2011 - 8:09am | 119Laboratory Corporation of America Holdings (NYSE: LH) today announced the commencement of its cash tender offer for all outstanding shares of the common stock of Orchid Cellmark Inc. (NASDAQ: ORCH) for $2.80 per share. The Board of Directors of Orchid Cellmark has determined that the agreement...
-
Oppenheimer Reports In-Line 1Q Results For Lincare Holdings
Tuesday, April 19, 2011 - 8:07am | 107According to Oppenheimer, Lincare Holdings (NASDAQ: LNCR) reported 1Q11 EPS of $0.49, in line with estimate and consensus. Oppenheimer reported that results were generally in line, as a slightly lower tax rate (+$0.01) and share count offset some margin pressure. “During the quarter, the company...
-
Oppenheimer Summary
Tuesday, April 19, 2011 - 7:22am | 121According to Oppenheimer, HCA (NYSE: HCA) is initiating with an Outperform rating. Eaton Corp (NYSE: ETN) is upgraded to Outperform. Estimates and price targets are increased on Citigroup (NYSE: C), Fortress Investment Group (NYSE: FIG), WW Grainger (NYSE: GWW), KepCorp (NYSE: KEY), KKR & Co (...
-
Top 4 Small-Cap Stocks In The Home Health Care Industry With The Highest ROE (LHCG, AFAM, CHE, AMED)
Tuesday, April 19, 2011 - 1:11am | 133Below are the top small-cap home health care stocks on the NYSE and the NASDAQ in terms of return on equity. The trailing-twelve-month return on equity at LHC Group (NASDAQ: LHCG) is 24.62%. LHCG's PEG ratio is 0.84. The trailing-twelve-month return on equity at Almost Family Inc (NASDAQ: AFAM)...
-
Lincare Holdings Reports Q1 EPS of $0.49 vs. $0.49 Estimate; Revenue $431.6M vs. $431.48M Estimate (LNCR)
Monday, April 18, 2011 - 4:33pm | 23Lincare Holdings (NASDAQ: LNCR) Reports Q1 EPS of $0.49 vs. $0.49 Estimate; Revenue $431.6M vs. $431.48M Estimate.
-
Quest Diagnostics Extends Tender Offer for all Outstanding Shares of Celera Corporation to May 2
Monday, April 18, 2011 - 11:15am | 96Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostics testing, information and services, announced today that, in connection with the entry by it and Celera Corporation (NASDAQ: CRA) into a memorandum of understanding providing for the settlement of previously...
-
Quest Diagnostics Launches Hepatitis C Virus Therapy Test Based on IL28B Gene Variants
Monday, April 18, 2011 - 9:33am | 122Quest Diagnostics Incorporated (NYSE: DGX) today announced the availability of its AccuType® IL28B test for aiding in the prediction of patient response to peginterferon alpha-based therapy for hepatitis C virus HCV infection. Quest Diagnostics is now offering the test to physicians and other...
-
Celera Announces Settlement with Putative Class Action Plaintiffs Regarding Acquisition by Quest Diagnostics
Monday, April 18, 2011 - 9:33am | 216Celera Corporation (NASDAQ: CRA) today announced that Celera and other named defendants have today entered into a memorandum of understanding with plaintiffs' counsel in connection with the previously consolidated putative class action lawsuits filed in Delaware and California state court in...
-
Amedisys Signs Definitive Agreement to Acquire Beacon Hospice
Monday, April 18, 2011 - 8:13am | 111Amedisys, Inc. (NASDAQ: AMED) today announced it has signed a definitive agreement to acquire Beacon Hospice, Inc. Beacon Hospice is headquartered in Boston, Mass.. Founded in 1993, Beacon has grown to include 23 free-standing locations and one inpatient unit, serving the states of Massachusetts...
-
Piper Jaffray Lowers athenahealth Doc Count Estimate For Q1
Friday, April 15, 2011 - 8:08am | 109According to Piper Jaffray, athenahealth (NASDAQ: ATHN) doc count estimate for Q1 is lowered. Piper Jaffray reported that it is lowering its Q1 doc count estimate to 620 from 820 because West Penn Alleghany (a large Enterprise client signed in November 2010) did not go live during Q1. “We...
-
Puts Purchased on Omnicare, Inc. (OCR)
Thursday, April 14, 2011 - 12:38pm | 143Shares of Omnicare, Inc. (NYSE: OCR) are lower on the session by 0.62%, currently trading at $30.41. The stock has been moving largely higher over the past six months and is currently trading above the 50-day and 200-day moving averages. Options traders are buying puts on the name today. A short...